Stevanato Group S.p.A. (STVN)
Automate Your Wheel Strategy on STVN
With Tiblio's Option Bot, you can configure your own wheel strategy including STVN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STVN
- Rev/Share 4.1211
- Book/Share 5.1884
- PB 4.2717
- Debt/Equity 0.2778
- CurrentRatio 1.825
- ROIC 0.0649
- MktCap 6048119228.5248
- FreeCF/Share -0.3614
- PFCF -61.3275
- PE 48.1995
- Debt/Assets 0.1692
- DivYield 0.0024
- ROE 0.0918
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | STVN | Wolfe Research | -- | Outperform | -- | $28 | Dec. 13, 2024 |
| Resumed | STVN | Morgan Stanley | -- | Equal Weight | -- | $23 | Dec. 3, 2024 |
News
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Stevanato (STVN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
MKKGY or STVN: Which Is the Better Value Stock Right Now?
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical - Drugs stocks are likely familiar with Merck KGaA (MKKGY) and Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Stevanato (STVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Stevanato: Expansion In Italy And The U.S. Will Pave The Way
Published: July 22, 2025 by: Seeking Alpha
Sentiment: Positive
The new facility in the U.S. expects to generate €500 million in annual revenues by 2028. The global drug containment solution market is expected to grow at an 8% CAGR from 2024 to 2030. In this market, Stevanato has a competitive advantage. Stevanato's PP&E has increased by 304.61% between 2018 and Q1 2025, indicating the significant investment that the company has dedicated to expanding its operations.
Read More
CPRX or STVN: Which Is the Better Value Stock Right Now?
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Drugs stocks are likely familiar with Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
USNA vs. STVN: Which Stock Is the Better Value Option?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
Read More
GRFS vs. STVN: Which Stock Is the Better Value Option?
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Stevanato Group (STVN) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.09 per share a year ago.
Read More
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript
Published: March 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Stevanato Group S.p.A. (NYSE:STVN ) Q4 2024 Earnings Conference Call March 6, 2025 8:30 AM ET Company Participants Lisa Miles - SVP, IR Franco Stevanato - Chairman and CEO Marco Dal Lago - CFO Conference Call Participants Michael Ryskin - Bank of America Matt Larew - William Blair Patrick Donnelly - Citi David Windley - Jefferies Pete Lukas - CJS Securities Anna Snopkowski - KeyBanc Tejas Savant - Morgan Stanley Doug Schenkel - Wolfe Research Operator Good afternoon.
Read More
USNA or STVN: Which Is the Better Value Stock Right Now?
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Read More
About Stevanato Group S.p.A. (STVN)
- IPO Date 2021-07-16
- Website https://www.stevanatogroup.com
- Industry Medical - Instruments & Supplies
- CEO Franco Stevanato
- Employees 5521